BioWorks 8: AI-Driven Drug Discovery with Alex Zhavoronkov
Update: 2023-05-20
Description
In which Alex Zhavoronkov, founder and CEO of Insilico Medicine, discusses how AI can accelerate drug R&D, from target identification to clinical trials. He also shares his own path from computer science to biotech, explains how Insilico’s business model has evolved, and gives advice on leading interdisciplinary teams.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
